{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:33:22Z","timestamp":1791113602010,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jaad.2009.05.017","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T13:05:30Z","timestamp":1259327130000},"page":"838-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Cyclosporine and psoriasis: 2008 National Psoriasis Foundation  Consensus Conference"],"prefix":"10.1016","volume":"62","author":[{"given":"David M.","family":"Rosmarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lebwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boni E.","family":"Elewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.05.017_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01986686","article-title":"Biological effects of cyclosporin A: a new antilymphocytic agent","volume":"43","author":"Borel","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.jaad.2009.05.017_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jaad.2009.05.017_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0190-9622(98)70325-1","article-title":"Cyclosporine consensus conference: with emphasis on the treatment of psoriasis","volume":"39","author":"Lebwohl","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.0366-077X.2004.05949.x","article-title":"Cyclosporin in psoriasis clinical practice: an international consensus statement","volume":"150","author":"Griffiths","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib5","first-page":"618","article-title":"The macrolide immunosuppressants in dermatology: mechanisms of action","volume":"12","author":"Marsland","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/1523-1747.ep12499782","article-title":"Studies of the effect of cyclosporine in psoriasis in vivo: combined effects on activated T lymphocytes and epidermal regenerative maturation","volume":"98","author":"Gottlieb","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0190-9622(95)90285-6","article-title":"Effects of cyclosporine on cytokines and cytokine receptors in psoriasis","volume":"33","author":"Prens","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2249.1991.tb08140.x","article-title":"Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A","volume":"84","author":"Horrocks","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2009.05.017_bib9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.180.3.1913","article-title":"Identification of cellular pathways of \u201ctype 1,\u201d Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis","volume":"180","author":"Haider","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2009.05.017_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/01.RES.0000027562.91075.56","article-title":"Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: role of vascular endothelial growth factor","volume":"91","author":"Alvarez-Arroyo","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.jaad.2009.05.017_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4400","article-title":"A systematic review of treatments for severe psoriasis","volume":"4","author":"Griffiths","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaad.2009.05.017_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM199101313240501","article-title":"Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial","volume":"324","author":"Ellis","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.05.017_bib13","first-page":"527","article-title":"Treatment of psoriasis with intermittent short course cyclosporin (Neoral): a multicenter study","volume":"136","author":"Berth-Jones","year":"1997","journal-title":"Br J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2133.1999.02977.x","article-title":"Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicenter, randomized study: the PISCES study group","volume":"141","author":"Ho","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1067\/mjd.2001.112400","article-title":"Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: a 2-year cohort study","volume":"44","author":"Ho","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00128071-200102010-00007","article-title":"Cyclosporine in severe psoriasis: results of a meta-analysis in 579 patients","volume":"2","author":"Faerber","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00403-007-0744-y","article-title":"German evidence-based guidelines for the treatment of psoriasis vulgaris (short version)","volume":"299","author":"Nast","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2009.05.017_bib18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1987.tb05826.x","article-title":"Generalized pustular psoriasis (von Zumbusch) responding to cyclosporin A","volume":"116","author":"Meinardi","year":"1987","journal-title":"Br J\u00a0Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000247289","article-title":"Management of erythrodermic psoriasis with low-dose cyclosporin","volume":"187","author":"Studio Italiano Multicentrico nella Psoriasi (SIMPSO)","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.017_bib20","first-page":"248","article-title":"Successful treatment of psoriatic nails with low-dose cyclosporine administration","volume":"17","author":"Syuto","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1056\/NEJMoa021359","article-title":"Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis","volume":"349","author":"Heydendael","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.05.017_bib23","first-page":"116","article-title":"Methotrexate vs cyclosporin in psoriasis: effectiveness, quality of life and safety; a randomized controlled trial","volume":"158","author":"Flytstrom","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib24","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0190-9622(95)91393-9","article-title":"Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study; German multicenter study","volume":"33","author":"Mrowietz","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0190-9622(97)80219-8","article-title":"Cyclosporine as maintenance therapy in patients with severe psoriasis","volume":"36","author":"Shupack","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1365-2133.1996.tb03885.x","article-title":"Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis: a prospective multicenter study","volume":"135","author":"Mahrle","year":"1996","journal-title":"Br J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib27","first-page":"2274","article-title":"A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis","volume":"28","author":"Salvarani","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1046\/j.1365-2133.2001.04183.x","article-title":"Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin","volume":"144","author":"Touw","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2133.1998.02122.x","article-title":"Renal function after 10 years' treatment with cyclosporin for psoriasis","volume":"138","author":"Powles","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0190-9622(96)90726-4","article-title":"Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure","volume":"35","author":"Lowe","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib31","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1523-1747.2003.12040.x","article-title":"Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study","volume":"120","author":"Paul","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaad.2008.03.023","article-title":"National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents","volume":"59","author":"Doherty","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(01)06179-7","article-title":"Squamous-cell cancer of the skin in patients given PUVA and cyclosporin: nested cohort crossover study","volume":"358","author":"Marcil","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2009.05.017_bib34","series-title":"Neoral [package insert]","year":"2005"},{"key":"10.1016\/j.jaad.2009.05.017_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1432-2277.2005.00078.x","article-title":"Generic cyclosporine formulations: more open questions than answers","volume":"18","author":"Cattaneo","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2009.05.017_bib36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00007691-200006000-00017","article-title":"Recommendations for bioequivalence testing of cyclosporine generics revisited","volume":"22","author":"Christians","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jaad.2009.05.017_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000017880","article-title":"Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicenter assessment of safety and tolerability","volume":"196","author":"Zachariae","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.017_bib38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/09546630500423914","article-title":"The use of cyclosporin in psoriasis","volume":"16","author":"Berth-Jones","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.05.017_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2133.2002.04836.x","article-title":"Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels","volume":"147","author":"Heydendael","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib40","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1346-8138.2007.00305.x","article-title":"Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris","volume":"34","author":"Hashizume","year":"2007","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2340\/00015555-0360","article-title":"Long-term follow-up of cancer risk in patients treated with short-term cyclosporine","volume":"88","author":"Vakeva","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.05.017_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007890-198610000-00009","article-title":"Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine","volume":"42","author":"Versluis","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2009.05.017_bib43","first-page":"553","article-title":"Influenza vaccination on renal transplant patients is safe and serologically effective","volume":"31","author":"Grekas","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.jaad.2009.05.017_bib44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<85::AID-JMV14>3.0.CO;2-H","article-title":"Efficacy of influenza vaccination in adult liver transplant recipients","volume":"61","author":"Soesman","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaad.2009.05.017_bib45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0190-9622(91)70247-Y","article-title":"Hypertriglyceridemia in patients with psoriasis treated with cyclosporine","volume":"25","author":"Grossman","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0190-9622(92)70213-Y","article-title":"Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis: an assessment of clinical significance when viewed as a risk factor for cardiovascular disease","volume":"27","author":"Stiller","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib47","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-199920050-00004","article-title":"Cyclosporin-induced hypertension: incidence, pathogenesis and management","volume":"20","author":"Taler","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2009.05.017_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2230.2002.00998.x","article-title":"Adverse effects with long-term cyclosporin for severe psoriasis","volume":"27","author":"Markham","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib49","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.05.017_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0272-6386(87)80045-8","article-title":"The effect of ethanol on serum cyclosporine A levels in renal transplant recipients","volume":"10","author":"Paul","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaad.2009.05.017_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0190-9622(96)80148-4","article-title":"Proceedings of the psoriasis combination and rotation therapy conference. Deer Valley, Utah, Oct. 7-9, 1994","volume":"34","author":"Menter","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib52","first-page":"50","article-title":"Combination of cyclosporine A and topical corticosteroid in the treatment of psoriasis","volume":"20","author":"Griffiths","year":"1988","journal-title":"Transplant Proc"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib53","first-page":"S62","article-title":"Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists","volume":"37","author":"Katz","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0190-9622(94)70138-5","article-title":"A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: results of a multicenter placebo-controlled study","volume":"31","author":"Grossman","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib55","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.136.12.1536","article-title":"Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability","volume":"136","author":"Ashcroft","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib56","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0190-9622(95)91286-X","article-title":"Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis: a clinical and pathologic study","volume":"33","author":"Gottlieb","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib57","first-page":"339","article-title":"Phototherapy: Uvb and PUVA","volume":"64","author":"Abel","year":"1999","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2009.05.017_bib58","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1365-2230.2001.00829.x","article-title":"Therapeutic strategies: rotational therapy and combinations","volume":"26","author":"van de Kerkhof","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1440-0960.1997.tb01697.x","article-title":"Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy","volume":"38","author":"Hunt","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib60","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0733-8635(18)30049-4","article-title":"Modifications of PUVA","volume":"13","author":"Momtaz","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2009.05.017_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2340\/00015555708990","article-title":"Combination therapy cyclosporin A\u2013PUVA in psoriasis","volume":"70","author":"Korstanje","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.05.017_bib62","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2133.1990.tb01481.x","article-title":"Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis","volume":"123","author":"Petzelbauer","year":"1990","journal-title":"Br J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2133.1997.d01-1187.x","article-title":"Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance","volume":"136","author":"van de Kerkhof","year":"1997","journal-title":"Br J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib64","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0190-9622(03)01144-7","article-title":"Combining the new biologic agents with our current psoriasis armamentarium","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/jdt.14.s2.7.16","article-title":"Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis","volume":"14","author":"Maryles","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.05.017_bib66","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0190-9622(08)81244-3","article-title":"Cyclosporine and methotrexate: a dangerous combination","volume":"23","author":"Korstanje","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib67","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/ard.2004.024463","article-title":"A randomized, double blind, placebo controlled, multicenter trial of combination therapy with methotrexate plus cyclosporin in patients with active psoriatic arthritis","volume":"64","author":"Fraser","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2009.05.017_bib68","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2230.2006.02153.x","article-title":"Methotrexate and cyclosporin combination for the treatment of severe psoriasis","volume":"31","author":"Aydin","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2133.1999.02976.x","article-title":"Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis","volume":"141","author":"Clark","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.clinthera.2006.02.002","article-title":"Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A","volume":"28","author":"Gul","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2009.05.017_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/000155599750011831","article-title":"Low dose cyclosporin A and methotrexate in the treatment of psoriasis","volume":"79","author":"Wong","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2009.05.017_bib72","first-page":"116","article-title":"Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis: a pilot study","volume":"186","author":"Mazzanti","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib73","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0190-9622(99)70363-4","article-title":"Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results","volume":"41","author":"Koo","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib74","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0190-9622(99)70361-0","article-title":"Acitretin combination therapy","volume":"41","author":"Roenigk","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000246070","article-title":"Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis","volume":"194","author":"Kuijpers","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.017_bib76","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2133.2007.08171.x","article-title":"Disseminated cryptococcal infection in a patient with severe psoriasis treated with efalizumab, methotrexate and cyclosporin","volume":"157","author":"Tuxen","year":"2007","journal-title":"Br J\u00a0Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sder.2005.01.002","article-title":"Combining traditional agents and biologics for the treatment of psoriasis","volume":"24","author":"Cather","year":"2005","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2009.05.017_bib78","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1396-0296.2004.04046.x","article-title":"Biologics in combination with nonbiologics: efficacy and safety","volume":"17","author":"Stebbins","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2009.05.017_bib79","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09546630701846103","article-title":"A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis","volume":"19","author":"Krueger","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.05.017_bib80","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/09546630601028794","article-title":"The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti-psoriatics in refractory psoriasis","volume":"17","author":"Langewouters","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2009.05.017_bib81","first-page":"738","article-title":"Subacute annular generalized pustular psoriasis treated with etanercept and cyclosporine combination","volume":"6","author":"Ricotti","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib82","first-page":"270","article-title":"Etanercept for the treatment of psoriasis: combination therapy with other modalities","volume":"3","author":"Strober","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib83","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-4632.2007.03158.x","article-title":"Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, phase IIIb study","volume":"46","author":"Menter","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib84","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaad.2004.07.043","article-title":"Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature","volume":"52","author":"Dadlani","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib85","first-page":"599","article-title":"Cyclosporine A in juvenile idiopathic arthritis: results of the PRCSG\/PRINTO phase IV post marketing surveillance study","volume":"24","author":"Ruperto","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib86","first-page":"203","article-title":"Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis: results of a preliminary study","volume":"11","author":"Pistoia","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1525-1470.2001.018003246.x","article-title":"Low dose cyclosporin A treatment in generalized pustular psoriasis","volume":"18","author":"Kilic","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib88","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1525-1470.2006.00247.x","article-title":"Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin\/narrowband ultraviolet B phototherapy","volume":"23","author":"Kim","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib89","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1525-1470.2007.00549.x","article-title":"Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema","volume":"24","author":"Pedreira","year":"2007","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib90","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2006.03.031","article-title":"Preferred methods of excess hair removal in pediatric patients with lung transplantation","volume":"55","author":"Fisher","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib91","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2004.11.035","article-title":"Pregnancy outcome after renal allograft transplantation: 15 years experience","volume":"121","author":"Ghanem","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jaad.2009.05.017_bib92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1399-0012.2006.00627.x","article-title":"Pregnancy after renal transplantation\u2013a five-year single-center experience","volume":"21","author":"Oliveira","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jaad.2009.05.017_bib93","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.transproceed.2006.06.020","article-title":"Outcome of pregnancy in renal allograft recipients: SIUT experience","volume":"38","author":"Naqvi","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.05.017_bib94","first-page":"65","article-title":"Pregnancies in renal transplant recipients\u2013with a focus on babies","volume":"9","author":"Basri","year":"2004","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jaad.2009.05.017_bib95","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/lt.20810","article-title":"Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients","volume":"12","author":"Christopher","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2009.05.017_bib96","first-page":"1364","article-title":"Prevention of abortion by cyclosporin treatment of fulminant ulcerative colitis during pregnancy","volume":"55","author":"Angelberger","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2009.05.017_bib97","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1572-0241.2007.01756.x","article-title":"Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes","volume":"103","author":"Reddy","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.05.017_bib98","series-title":"Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs","author":"Ostensen","year":"2008"},{"key":"10.1016\/j.jaad.2009.05.017_bib99","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.transproceed.2007.11.052","article-title":"Pregnancy after renal transplantation: ten-year single-center experience","volume":"40","author":"Ghafari","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.05.017_bib100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/0961203307079569","article-title":"Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants","volume":"16","author":"Biggioggero","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.jaad.2009.05.017_bib101","first-page":"151","article-title":"In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants","volume":"56","author":"Meregalli","year":"2005","journal-title":"Arh Hig Rada Toksikol"},{"key":"10.1016\/j.jaad.2009.05.017_bib102","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1097\/01.ASN.0000139069.59466.D8","article-title":"Long-term effects of in utero exposure to cyclosporin A on renal function in the rabbit","volume":"15","author":"Tendron-Franzin","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib103","doi-asserted-by":"crossref","first-page":"208S","DOI":"10.1016\/j.transproceed.2004.01.012","article-title":"Renal outcome of children exposed to cyclosporine in utero","volume":"36","author":"Cochat","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.05.017_bib104","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.transproceed.2004.08.029","article-title":"Management of pregnancy in transplant recipients","volume":"36","author":"Sivaraman","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.05.017_bib105","series-title":"Gengraf [package insert]. Physicians' Desk Reference","year":"2007"},{"key":"10.1016\/j.jaad.2009.05.017_bib106","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-4362.2003.01760.x","article-title":"Clinical course of psoriasis during pregnancy","volume":"42","author":"Raychaudhuri","year":"2003","journal-title":"Int J Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2009.05.017_bib107","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1053\/jlts.2002.35852","article-title":"Impact of immunosuppressive therapy on recurrence of hepatitis C","volume":"8","author":"Everson","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jaad.2009.05.017_bib108","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.transproceed.2006.08.055","article-title":"Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology","volume":"38","author":"Oton","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.05.017_bib109","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1365-2133.2007.07873.x","article-title":"Cyclosporin treatment of psoriasis in a patient with chronic hepatitis C","volume":"156","author":"Imafuku","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib110","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.transproceed.2006.02.069","article-title":"Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation?","volume":"38","author":"Kamar","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2009.05.017_bib111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-4362.1999.00690.x","article-title":"Long-term administration of cyclosporin A to HCV-antibody-positive patients with dermatologic diseases","volume":"38","author":"Miura","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib112","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0190-9622(97)70160-9","article-title":"Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine","volume":"37","author":"Tourne","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.05.017_bib113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000051694","article-title":"Cyclosporin for atopic dermatitis in children","volume":"203","author":"Harper","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.05.017_bib114","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2006.02023.x","article-title":"Cyclosporin in the treatment of patients with atopic eczema\u2013a systematic review and meta-analysis","volume":"21","author":"Schmitt","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2009.05.017_bib115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Bar Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2009.05.017_bib116","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00007890-199402270-00004","article-title":"National transplantation pregnancy registry\u2013outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients","volume":"57","author":"Armenti","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2009.05.017_bib117","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1396-0296.2004.04039.x","article-title":"Pediatric psoriasis and psoriatic arthritis","volume":"17","author":"Lewkowicz","year":"2004","journal-title":"Dermatol Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209006136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209006136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:15:46Z","timestamp":1759270546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209006136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0190962209006136"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.05.017","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}